Modulation of response to cancer chemotherapeutic agents by diet constituents - Is the available evidence sufficiently robust for rational advice for patients?

Cancer Treatment Reviews

Volumn 33, Issue 3, 2007, Pages 223-229

  D'Incalci, Maurizio ^a   Steward, William P ^b   Gescher, Andreas J ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Cytotoxic therapy; Diet; Drug interaction

Indexed keywords

ALPHA TOCOPHEROL; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; ASCORBIC ACID; BETA CAROTENE; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; DOCOSAHEXAENOIC ACID; DOXORUBICIN; ETOPOSIDE; FLAVONOID; FLUOROURACIL; FOLIC ACID; GENISTEIN; GLUTAMINE; METHOTREXATE; OLIVE OIL; PACLITAXEL; PROCARBAZINE; QUERCETIN; RETINOL; SELENIUM; UBIDECARENONE; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; ZINC;

ALOPECIA; ANTIOXIDANT ACTIVITY; CANCER; CANCER PATIENT; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; DIARRHEA; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INTOXICATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENTIATION; DRUG RESPONSE; DRUG SAFETY; ESOPHAGUS CANCER; EVIDENCE BASED MEDICINE; FOOD; FOOD COMPOSITION; FOOD DRUG INTERACTION; HUMAN; LOW DRUG DOSE; LUNG CANCER; LUNG SURGERY; MALNUTRITION; MONOTHERAPY; MUCOSA INFLAMMATION; NEPHROTOXICITY; NEUROBLASTOMA; NEUROTOXICITY; NONHUMAN; NUTRITIONAL STATUS; OXIDATIVE STRESS; PATIENT EDUCATION; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SINGLE DRUG DOSE; SURVIVAL TIME; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CISPLATIN; CLINICAL TRIALS; COUNSELING; DIET; DIETARY SUPPLEMENTS; DRUG INTERACTIONS; FOLIC ACID; HUMANS; MICE; NEOPLASMS; RATS; VITAMIN E;

EID: 34248637061     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2006.12.004     Document Type: Review

References (51)

1. Demark-Wahnefried W., Peterson B., McBride C., Lipkus I., and Clipp E. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer 88 3 (2000) 674-684
2. D'Incalci M., Steward W.P., and Gescher A.J. Use of cancer chemopreventive phytochemicals as antineoplastic agents. Lancet Oncol 6 11 (2005) 899-904
3. van Bokhorst-de van der S., van Leeuwen P.A., Kuik D.J., et al. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 86 3 (1999) 519-527
4. Federico A., Iodice P., Federico P., Del Rio A., Mellone M.C., and Catalano G. Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract. Eur J Clin Nutr 55 4 (2001) 293-297
5. Anthony H.M., and Schorah C.J. Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance. Br J Cancer 46 3 (1982) 354-367
6. Krasner N., and Dymock I.W. Ascorbic acid deficiency in malignant diseases: a clinical and biochemical study. Br J Cancer 30 2 (1974) 142-145
7. Rao P.B.R., Lagerlof B., Einhorn J., and Reizenstein P. Low serum-folic-acid in malignancy. Lancet 1 (1963) 1192-1193
8. Hoogstraten B., Baker H., and Gilbert H.S. Serum folate and serum vitamin B12 in patients with malignant hematology diseases. Cancer Res 25 11 (1965) 1933-1938
9. Magnus E.M. Folate activity in serum and red cells of patients with cancer. Cancer Res 27 3 (1967) 490-497
10. Pufulete M., Al-Ghnaniem R., Leather A.J., et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 124 5 (2003) 1240-1248
11. Almadori G., Bussu F., Galli J., et al. Serum folate and homocysteine levels in head and neck squamous cell carcinoma. Cancer 94 4 (2002) 1006-1011
12. Kato I., Dnistrian A.M., Schwartz M., et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer 79 11-12 (1999) 1917-1922
13. Jatoi A., Daly B.D., Kramer G., and Mason J.B. A cross-sectional study of vitamin intake in postoperative non-small cell lung cancer patients. J Surg Oncol 68 4 (1998) 231-236
14. Begleiter A., Leith M.K., Thliveris J.A., and Digby T. Dietary induction of NQO1 increases the antitumour activity of mitomycin C in human colon tumours in vivo. Br J Cancer 91 8 (2004) 1624-1631
15. Conklin K.A. Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37 1 (2000) 1-18
16. Salganik R.I. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 20 5 Suppl. (2001) 464S-472S discussion 73S-5S
17. Prasad K.N., Kumar A., Kochupillai V., and Cole W.C. High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr 18 1 (1999) 13-25
18. De Martinis B.S., and Bianchi M.D. Effect of vitamin C supplementation against cisplatin-induced toxicity and oxidative DNA damage in rats. Pharmacol Res 44 4 (2001) 317-320
19. Leonetti C., Biroccio A., Gabellini C., et al. Alpha-tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficacy. Int J Cancer 104 2 (2003) 243-250
20. Quiles J.L., Huertas J.R., Battino M., Mataix J., and Ramirez-Tortosa M.C. Antioxidant nutrients and adriamycin toxicity. Toxicology 180 1 (2002) 79-95
21. Parchure M., Ambaye R.Y., and Gokhale S.V. Combination of anticancer agents with folic acid in the treatment of murine leukaemia P388. Chemotherapy 30 2 (1984) 119-124
22. Mendelsohn L.G., Gates S.B., Habeck L.L., et al. The role of dietary folate in modulation of folate receptor expression, folylpolyglutamate synthetase activity and the efficacy and toxicity of lometrexol. Adv Enzyme Regul 36 (1996) 365-381
23. Branda R.F., Chen Z., Brooks E.M., Naud S.J., Trainer T.D., and McCormack J.J. Diet modulates the toxicity of cancer chemotherapy in rats. J Lab Clin Med 140 5 (2002) 358-368
24. Tucker J.M., Davis C., Kitchens M.E., et al. Response to 5-fluorouracil chemotherapy is modified by dietary folic acid deficiency in Apc(Min/+) mice. Cancer Lett 187 1-2 (2002) 153-162
25. Tran C.D., Howarth G.S., Coyle P., Philcox J.C., Rofe A.M., and Butler R.N. Dietary supplementation with zinc and a growth factor extract derived from bovine cheese whey improves methotrexate-damaged rat intestine. Am J Clin Nutr 77 5 (2003) 1296-1303
26. Cha M.C., Meckling K.A., and Stewart C. Dietary docosahexaenoic acid levels influence the outcome of arabinosylcytosine chemotherapy in L1210 leukemic mice. Nutr Cancer 44 2 (2002) 176-181
27. Taper H.S., and Roberfroid M.B. Nontoxic potentiation of cancer chemotherapy by dietary oligofructose or inulin. Nutr Cancer 38 1 (2000) 1-5
28. Jatoi A., Williams B.A., Marks R., et al. Exploring vitamin and mineral supplementation and purported clinical effects in patients with small cell lung cancer: results from the Mayo Clinic lung cancer cohort. Nutr Cancer 51 1 (2005) 7-12
29. Lesperance M.L., Olivotto I.A., Forde N., et al. Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study. Breast Cancer Res Treat 76 2 (2002) 137-143
30. Branda R.F., Naud S.J., Brooks E.M., Chen Z., and Muss H. Effect of vitamin B12, folate, and dietary supplements on breast carcinoma chemotherapy-induced mucositis and neutropenia. Cancer 101 5 (2004) 1058-1064
31. Sellers T.A., Alberts S.R., Vierkant R.A., et al. High-folate diets and breast cancer survival in a prospective cohort study. Nutr Cancer 44 2 (2002) 139-144
32. Meyerhardt J.A., Heseltine D., Campos H., et al. Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy. J Clin Oncol 23 33 (2005) 8453-8460
33. Weijl N.I., Elsendoorn T.J., Lentjes E.G., et al. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur J Cancer 40 11 (2004) 1713-1723
34. Pace A., Savarese A., Picardo M., et al. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol 21 5 (2003) 927-931
35. Hu Y.J., Chen Y., Zhang Y.Q., et al. The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients. Biol Trace Elem Res 56 3 (1997) 331-341
36. Blanke C.D., Stipanov M., Morrow J., et al. A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies. Invest New Drugs 19 1 (2001) 21-27
37. Weitzman S.A., Lorell B., and Carey R.W. Prospective study of tocopherol prophylaxis for anthracycline cardiac toxicity. Curr Ther Res Clin Exp 28 (1980) 682-686
38. Legha S.S., Wang Y.M., Mackay B., et al. Clinical and pharmacologic investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicity. Ann N Y Acad Sci 393 (1982) 411-418
39. Perez J.E., Macchiavelli M., Leone B.A., et al. High-dose alpha-tocopherol as a preventive of doxorubicin-induced alopecia. Cancer Treat Rep 70 10 (1986) 1213-1214
40. Wagdi P., Fluri M., Aeschbacher B., Fikrle A., and Meier B. Cardioprotection in patients undergoing chemo- and/or radiotherapy for neoplastic disease. A pilot study. Jpn Heart J 37 3 (1996) 353-359
41. Sieja K. Protective role of selenium against the toxicity of multi-drug chemotherapy in patients with ovarian cancer. Pharmazie 55 12 (2000) 958-959
42. Savarese D.M., Savy G., Vahdat L., Wischmeyer P.E., and Corey B. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev 29 6 (2003) 501-513
43. Ladas E.J., Jacobson J.S., Kennedy D.D., Teel K., Fleischauer A., and Kelly K.M. Antioxidants and cancer therapy: a systematic review. J Clin Oncol 22 3 (2004) 517-528
44. D'Andrea G.M. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 55 5 (2005) 319-321
45. Davies A.A., Davey Smith G., Harbord R., et al. Nutritional interventions and outcome in patients with cancer or preinvasive lesions: systematic review. J Natl Cancer Inst 98 14 (2006) 961-973
46. Altundag K., Silay Y.S., Altundag O., Yigitbasi O.G., Gundeslioglu O., and Gunduz M. Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients. Med Hypotheses 64 6 (2005) 1162-1165
47. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3 10 (2003) 768-780
48. Cao S., Durrani F.A., and Rustum Y.M. Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin Cancer Res 10 7 (2004) 2561-2569
49. Han J.Y., Lim H.S., Shin E.S., et al. Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin. J Clin Oncol 24 15 (2006) 2237-2244
50. *28 polymorphism to determine serum bilirubin levels in humans. J Nutr 135 5 (2005) 1051-1055
51. McCarty M.F., and Block K.I. Toward a core nutraceutical program for cancer management. Integr Cancer Ther 5 2 (2006) 150-171